Keywords: ATRA; ATO; CML; Promyelocytic; Blast crisis;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Cancer; Chronic myeloid leukemia; CML; Age of diagnosis; Agricultural exposure;
Keywords: 25(OH)D; 25-hydroxyvitamin D; AAPCCAAN; American Academy of Pediatrics' Committee on Child Abuse and Neglect; CPS; child protective services; CML; classical metaphyseal lesion; MUFVSH; multiple unexplained fractures in various stages of healing; TPN; to
Keywords: ALL; acute lymphoblastic leukaemia; AML; acute myeloid leukaemia; APL; acute promyelocytic leukaemia; ASR; age standardised incidence rates; CI; confidence interval; CML; chronic myeloid leukaemia; ECP; Eastern Cape Province; HMs; haematological malignanc
Keywords: K-1; the dissociation rate constant; MLs; the metal-organic complexes; CM; the concentration of free ionic soil metals; CML; the labile concentration of soil metal-organic complexes; DGT; diffusive gradients in thin-films; WHAM; Windermere Humic Aqueous M
Keywords: Hematopoietic stem cell transplantation; Taste changes; Biographical disruption; Qualitative research; HSCT; Haematopoietic stem cell transplantation; TBI; Total body irradiation; AML; Acute myeloid leukaemia; CML; Chronic myeloid leukaemia; ALL; Acute ly
Keywords: ALL; acute lymphoid leukemia; AML; acute myeloid leukemia; CLL; chronic lymphoid leukemia; CML; chronic myeloid leukemia; Hb; hemoglobin; WBC; white blood cell;
Keywords: AGEs; advanced glycation end products; CEL; Nε-(carboxyethyl) lysine; CMA; NÏ-(carboxymethyl) arginine; CML; Nε-(carboxymethyl) lysine; H2O2; hydrogen peroxide; HCC; hepato-cellular carcinoma-; HMGB1; high mobility group box-1; NAFLD; nonalcoholic fatt
Keywords: APC; antigen-presenting cell; BMT; bone marrow transplantation; CKBMT; combined kidney and bone marrow transplantation; CML; cell-mediated lympholysis; DLI; donor leukocyte infusions; GVHD; graft-vs-host disease; GVL; graft-vs-leukemia/lymphoma; LDA; limi
Keywords: EV; extracellular vesicles; ILVs; intraluminal vesicles; BMSCs; bone marrow stromal cells; AML; acute myeloid leukemia; CML; chronic myelogenous leukemia; CLL; chronic lymphocytic leukemia; ALL; acute lymphoblastic leukemia; EGF; epidermal growth factor;
Keywords: CML; DADI; Natural killer cell; Stop trial; Treatment-free remission;
Keywords: AGE; advanced glycation end product; ARP; Amadori rearrangement product; aw; water activity; CEL; N-ε-carboxyethyllysine; CML; N-ε-carboxymethyllysine; HMF; 5-hydroxymethylfurfural; LOD; limit of detection; LOQ; limit of quantification; MG-H1; methylgly
Keywords: Nε-(2-furoylmethyl)-l-lysine (furosine, PubChem CID123889); Nε-(carboxymethyl)-l-lysine (CML, PubChem CID123800); lysine (PubChem CID5962); N-(1-deoxy-d-fructos-1-yl)-l-phenylalanine (PubChem CID71316982); N-(1-deoxy-d-fructos-1-yl)-l-lysine (PubChem CI
Keywords: ABC; ATP-binding cassette; AKT; V-Akt murine thymoma viral oncogene homolog; ALDH1; aldehyde dehydrogenase 1; AR; androgen receptor; Bad; Bcl-2-associated death promoter; Bak; Bcl-2 homologous antagonist killer; Bax; Bcl-2-associated X protein; Bcl-2; B-c
Keywords: CML; CML advocates; TFR; TKIs (Tyrosine Kinase Inhibitors); Therapy discontinuation;
Keywords: CML; Centrum for Milieukunde; EPD; Environmental product declarations; EURO; European emission standards; IBU; Institut Bauen und Umwelt; ISO; International Organization for Standardization; LCA; Life cycle assessment; LSP; Logistics service provider; RER
Keywords: AD; Alzheimer's disease; AGEs; advanced glycation end products; BBB; blood-brain barrier; BDNF; brain-derived nerve growth factor; CML; carboxymethyllysine; CMRg; cerebral metabolic rate of glucose; DAMPs; damage-associated molecular patterns; GLUT; gluco
Keywords: AGE; Advanced glycation endproduct; CML; Nε-(carboxymethyl)lysine; CEL; Nε-(carboxyethyl)lysine; MG-H1; 5-hydro-5-methylimidazolone; MMP; Matrix metalloproteinase; TIMP; Tissue inhibitor of metalloproteinase; Type 1 diabetes; AGEs; MMPs; TIMP-1; Cardiov
Keywords: 5FU; 5-fluorouracil; 95%CI; 95% confidence interval; AA; amino acid; AFP; alpha fetoprotein; AML; actue myeloid leukemia; Ang2; angiopoietin 2; ATP; adenosine triphosphate; BCLC; Barcelona-Clinic Liver Cancer classification; BSC; best supportive care; CAP
Keywords: A. Wood fibers; B. Adhesion; D. Mechanical testing; D. Surface analysis; ATR- FTIR; attenuated total reflectance -fourier transform infrared spectroscopy; CML; compound middle lamella; Er; reduced elastic modulus; H; hardness; L; lumen; MDF; medium densit
Keywords: AML; acute myeloid leukemia; ChIP; Chromatin immunoprecipitation; CML; chronic myeloid leukemia; ECM; extracellular matrix; GO; gene ontology; CD29/ITGB1; integrin beta 1; HIP1; huntingtin interacting protein; DAB2; disabled homolog 2; SDC1; syndecan 1; L
Keywords: AGE; advanced glycation end-product; GSH; reduced glutathione; MGO; methylglyoxal; 3-DG; 3-deoxyglucosone; CML; Nε-(carboxymethyl)-lysine; CEL; Nε-(carboxyethyl)-lysine; ROS; reactive oxygen species; AMD; age-related macular degeneration; RPE; retinal p
Keywords: BATF; basic leucine zipper transcription factor; BM; bone marrow; Bregs; regulatory B cells; BTLA; B and T lymphocyte attenuator; CFSE; carboxyfluorescein succinimidyl ester; CML; cell mediated lympholysis; CNI; calcineurin inhibitor; CPM; counts per minu
Keywords: Basophil; mast cell; development; allergy; anaphylaxis; inflammation; autoimmune disease; infection; antigen presentation; IL-4; protease; APC; Antigen-presenting cell; CIU; Chronic idiopathic urticaria; CML; Chronic myeloid leukemia; EoE; Eosinophilic es
Keywords: AD; Alzheimer'sdisease; AGEs; advanced glycation end products; CKD; chronic kidney disease; CML; Nε-(carboxylmethyl)-l-lysine; CEL; Nε-(carboxylethyl)-l-lysine; ELISA; enzyme-linked immunosorbent assay; ESRD; end-stagerenal disease; FFQ; food frequenc
Keywords: AA-PEG; aminoethylanisamide-polyethylene glycol; AD; Alzheimer's disease; BBB; blood-brain barrier; BDNF; brain derived neurotrophic factor; CML; Chronic Myeloid Leukemia; CPPs; cell penetrating peptides; c(RGDyK; cyclo(Arg-Gly-Asp-D-Tyr-Lys) peptide; DSP
Keywords: ALL; acute lymphoblastic leukemia; AML; acute myeloid leukemia; CLL; B-cell chronic lymphocytic leukemia; CML; chronic myelogenous leukemia; ERK; extracellular signal-regulated kinase; FN3; fibronectin type-III (domain); GBM; glioblastoma multiforme; JMML
Keywords: ACC; acetyl-CoA carboxylase; ALDOA; aldolase A; AIs; aromatase inhibitors; AMPK; AMP-activated protein kinase; BC; breast cancer; CML; chronic myelogenous leukemia; CT; computed tomography; CPT1; carnitine palmitoyltransferase 1; CRC; colorectal cancer; 2
Keywords: AML; acute myeloid leukemia; APL; acute promyelocytic leukemia; ADAM; a disintegrin and metalloproteinase enzymes; ALDH; aldehyde dehydrogenase; ABC; ATP - binding cassette; BWS; Beckwith-Wiedemann syndrome; BMP; bone morphogenetic proteins; CSC; cancer s
Keywords: Analysis of survival; CML; Event free survival; Overall survival; Progression free survival;
Keywords: OML; Odisha maize line; QPM; quality protein maize; CIMMYT; Centro Internacional de Mejoramiento de Maiz y Trigo (International Maize and Wheat Improvement Center); CML; CIMMYT maize line; F1; first filial generation; F1 and F2; first and second filial ge
Keywords: CML; classic metaphyseal lesion; CPT; child protection team; Fractures; Humerus injuries; Child abuse;
Keywords: Olive leaf; Hydroxytyrosol; Antiglycative activity; Dietary advanced glycation endproducts; 1,2-dicarbonyl compounds; Hydroxymethylfurfural; Maillard reaction; Methylglyoxal (PubChem CID: 880); Glyoxal (PubChem CID: 7860); 3-deoxyglucosone (PubChem CID: 1
Keywords: Food allergy; alarmins; glycation; advanced glycated end-products; receptor for advanced glycated end-products; AGE; Advanced glycated end-products; CML; N(ε)-carboxymethyllysine; DC; Dendritic cell; HMGB1; High molecular group box 1; OVA; Ovalbumin; RAG
Keywords: Biogas production; Microalga; Anaerobic digestion; Environmental impact; Life Cycle Sustainability Assessment; AbD; Abiotic Depletion; AMBL; Advanced Micro-bio-loop; AP; Acidification Potential; CBPS; Conventional Biogas Production System; CML; Centre for
Keywords: ASH; American Society of Hematology; ATAP; amphipathic tail-anchoring peptide; BAD; BCL-2-associated death promoter protein; BAK; BCL-2 homologous antagonist killer; BAX; BCL-2-associated X protein; BCL-2; B-cell lymphoma 2; BCL-w (BCL2L2); BCL-2-like pro
Keywords: JAK; Janus kinase; STAT; signal transducers and activators of transcription; EPOR; erythropoietin receptor; TPOR; thrombopoietin receptor; G-CSFR; granulocyte colony stimulating factor receptor; γc; common gamma chain; SCID; severe combined immunodeficie
Keywords: AML; acute myeloid leukemia; MUFA; monounsaturated fatty acid; CML; chronic myelogenous leukemia; ALL; acute lymphoblastic leukemia; FAO; fatty acid oxidation; CPT1a; carnitine palmitate transferase 1a; SCD1; stearoyl CoA desaturase 1; FAB; French-America
Keywords: Cardiotoxicity; Bone marrow transplantation; Speckle-tracking; 3D echocardiography; 2D; Two-dimensional; 3D; Three-dimensional; AML; Acute myeloid leukemia; BEAM; Carmustine, etoposide, cytarabine, and melphalan; BMT; Bone marrow transplantation; Bu-Thio-
Keywords: ALL; acute lymphocytic leukemia; Brms1; breast cancer metastasis suppressor 1; CerS; ceramide synthase; CML; chronic myeloid leukemia; DES; desaturase enzyme; Drp1; dynamin-related protein 1; ER; endoplasmic reticulum; GlcCer; glucosylceramide; GLUT1; glu
Keywords: BM parameters; CML; EUTOS score; Peripheral blood parameters; Sokal score;
Keywords: Chronic myeloid leukemia; Blast crisis; Disease progression mechanisms; Causal modeling; Bayesian networks; Feedback loops; AP; accelerated phase; BC; blast crisis; CHR; complete hematological response; CML; chronic myeloid leukemia; CP; chronic phase; DA
Keywords: AML; acute myeloid leukemia; BRCA; breast cancer; BRCC3; BRCA1/BRCA2-Containing Complex Subunit 3; C; constant; CLL; chronic lymphocytic leukemia; CML; chronic myeloid leukemia; CSC; cancer stem-like cell; EGFR; epidermal growth factor receptor; EMT; epit
Keywords: AC; adenocarcinomas; AdIL-32; adenoviral overexpression of IL-32; AICD; activation-induced cell death; BAVECs; bovine aortic vascular endothelial cells; BLP; bacterial lipoprotein; CML; chronic myeloid leukemia; Con A; concanavalin A; COPD; chronic obstru
Keywords: CML; chronic myeloid leukemia; GIPAP; Glivec International Patient Assistance Program; Chronic myeloid leukemia; Age at diagnosis; Income; Occupation;
Keywords: CML; Imatinib mesylate; Second cancers; Side effects;
Keywords: APC; Allophycocyanin; CML; cell mediated lympholysis; cpm; counts per minute; CTL; cytotoxic T lymphocyte; E:T ratio; effector:target ratio; FITC; fluorescein isothiocyanate; HLA; human leukocyte antigen; IFN; interferon; IL; interleukin; MLC; mixed lymph
Keywords: CCyR; complete cytogenetic response; CML; chronic myeloid leukemia; G-CSF; granulocyte-colony stimulating factor; GM-CSF; granulocyte-monocyte-colony stimulating factor; HR; high risk; IL; interleukin; INF; interferon; IR; intermediate risk; LR; low risk;
Keywords: CML; classic metaphyseal lesions; FUSS; follow-up skeletal survey; SS; skeletal survey; Physical abuse; Fracture; Follow-up skeletal survey; Variability;
Keywords: ALL; acute lymphoblastic leukemia; AML; acute myeloid leukemia; BM; bone marrow; CML; chronic myelogenous leukemia; G-CSF; granulocyte colony stimulating factor; HIF-1α; hypoxia-inducible factor -1α; HSC; hematopoietic stem cell; IL; Interleukin; LT-HSC